CVS bought Omnicare in 2015 for $12.7 billion in an effort to focus on its long-term care business, such as work with senior living facilities and nursing homes.
“We continue to evaluate our portfolio strategically and are making decisions around assets that don’t fit into our portfolio,” Karen Lynch, president and CEO of CVS Health, said in the call. “Strategically, Omnicare is a good example of that. Bswift was a good example of that.”
Bswift is a benefits technology company that CVS Health plans to sell to Francisco Partners, a technology investment firm based in San Francisco.
The retail chain attributed most of its third-quarter losses to opioid-related settlements, which the company predicts will cost $5 billion over the next 10 years.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
